Patent · US Active

Biological markers for identifying patients for treatment with VEGF antagonists

US10364466B2 · kind B2 · utility

6Cited by

0References

17Claims

0Family size

Assignee

Genentech, Inc. · US

Inventors

Carlos Bais · San Francisco, US
Matthew Brauer · San Francisco, US
Mallika Singh · San Francisco, US
Maike Schmidt · San Francisco, US

Key dates

Filing date	Mar 15, 2013
Grant date	Jul 30, 2019
Priority date	—
Expiry date	Nov 29, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/52
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides methods and compositions to detect expression of one or more biomarkers for identifying and treating patients who are likely to be responsive to VEGF antagonist therapy. The invention also provides kits and articles of manufacture for use in the methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.